跳至主要内容
临床试验/NCT01067599
NCT01067599已完成不适用

Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 Effects of Switching Levels of Nicotine and TSNA in Products on Smokeless Tobacco Use

University of Minnesota4 个研究点 分布在 1 个国家目标入组 278 人开始时间: 2012年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
278
试验地点
4
主要终点
1. To determine if switching to ST products with reduced toxicant levels will result in reduction of biomarkers of exposure and toxicity. 2. To determine the nicotine levels of ST that would lead to the greatest reduction in tobacco toxicant exposure.

研究概览

简要总结

The research project will determine the level of nicotine in ST products that will lead to the greatest reduction in toxicant exposure

详细描述

This is a randomized, multi-site trial determining the effects of switching smokeless tobacco (ST) users to lower toxicant ST products which vary in nicotine levels on biomarkers of exposure and patterns of use. ST users will undergo a two week baseline assessment period and then randomly assigned to one of three oral tobacco products (lower NNK plus NNN product with three different levels of nicotine) for a period of 8-weeks. Follow-up will occur at 9 and 20 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Using a consistent and daily amount of ST with specific nicotine and tobacco-specific nitrosamine (TSNA) levels for the past year;
  • In good physical health (no unstable medical condition);
  • Stable, good mental health (e.g., no recent unstable or untreated psychiatric diagnosis, including substance abuse, as determined by the DSM-IV criteria).

排除标准

  • Subjects must not be currently using other tobacco or nicotine products.
  • Female subjects cannot be pregnant or nursing.

研究组 & 干预措施

Low nicotine

Active Comparator

Conventional smokeless tobacco product with 1) NNN plus NNK of <2 μg/gram and nicotine levels of >5 mg/g wet weight

干预措施: Low nicotine (Other)

Medium nicotine

Active Comparator

Conventional smokeless tobacco product with ) NNN plus NNK of <2 μg/gram and nicotine levels of 3-5 mg/g wet weight.

干预措施: Medium nicotine (Other)

High nicotine

Active Comparator

Conventional smokeless tobacco product with NNN plus NNK of <2 μg/gram and nicotine levels of <3 mg/g wet weight

干预措施: High nicotine (Other)

结局指标

主要结局

1. To determine if switching to ST products with reduced toxicant levels will result in reduction of biomarkers of exposure and toxicity. 2. To determine the nicotine levels of ST that would lead to the greatest reduction in tobacco toxicant exposure.

时间窗: 8 weeks

次要结局

  • To determine the extent to which varying low nicotine ST products leads to compensatory tobacco use.(8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Novel Determinants and Measures of Smokeless Tobacco... | 临床试验